VSL#3®

DIETARY_SUPPLEMENT5 trials

Sponsors

Hadassah Medical Organization, Charite University, Berlin, Germany, VSL Pharmaceuticals, Nordsjaellands Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions

AgedCrohn's DiseaseDietary ModificationHealthyIrritable Bowel SyndromeLong COVIDMicrobiomeProbiotics

Early Phase 1

New E-Service for a Dietary Approach to the Elderly

CompletedNCT01179789

Charite University, Berlin, GermanyAged, Healthy

Start: 2009-10-31End: 2011-06-30Target: 48Updated: 2011-10-31

Phase 4

VSL#3 Treatment in Children With Crohn's Disease

Hadassah Medical OrganizationCrohn's Disease

Start: 2009-08-31End: 2010-12-31Target: 300Updated: 2009-08-18

Unknown Phase

PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis

TerminatedNCT03415711

VSL PharmaceuticalsUlcerative Colitis

Start: 2017-04-28End: 2019-04-24Updated: 2020-01-18

One Year Home Monitoring and Treatment of IBS Patients

Nordsjaellands HospitalDietary Modification, eHealth, Irritable Bowel Syndrome +2

Start: 2018-09-23End: 2020-12-20Target: 124Updated: 2020-10-19

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoLong COVID

Start: 2022-11-03End: 2023-11-03Target: 96Updated: 2023-05-24

Related Papers

VSL#3® supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial

British Journal of Biomedical Science2026-07-27

Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial

Journal of Medical Internet Research2021-12-1435 citations

Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The "RISTOMED project": Randomized controlled trial in healthy older people.

2014-10-0890 citations